Patents by Inventor Nabil Enattah

Nabil Enattah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Identification of a DNA variant associated with adult type hypolactasia
    Patent number: 10144979
    Abstract: The present invention relates to a nucleic acid molecule comprising a 5? portion of an intestinal lactase-phlorizine hydrolase (LPH) gene contributing to or indicative of the adult-type hypolactasia. The present invention further relates to methods for testing for the presence of or predisposition to adult-type hypolactasia that are based on the analysis of an SNP contained in the above recited nucleic acid molecule. Additionally, the present invention relates to diagnostic composition and kit useful in the detection of the presence of or predisposition to adult-type hypolactasia.
    Type: Grant
    Filed: August 24, 2012
    Date of Patent: December 4, 2018
    Assignee: NATIONAL PUBLIC HEALTH INSTITUTE
    Inventors: Leena Peltonen, Nabil Enattah, Irma Järvelä, Timo Sahi, Erkki Savilahti, Joseph Terwilliger
  • IDENTIFICATION OF A DNA VARIANT ASSOCIATED WITH ADULT TYPE HYPOLACTASIA
    Publication number: 20120329052
    Abstract: The present invention relates to a nucleic acid molecule comprising a 5? portion of an intestinal lactase-phlorizine hydrolase (LPH) gene contributing to or indicative of the adult-type hypolactasia. The present invention further relates to methods for testing for the presence of or predisposition to adult-type hypolactasia that are based on the analysis of an SNP contained in the above recited nucleic acid molecule. Additionally, the present invention relates to diagnostic composition and kit useful in the detection of the presence of or predisposition to adult-type hypolactasia.
    Type: Application
    Filed: August 24, 2012
    Publication date: December 27, 2012
    Applicant: National Public Health Institute
    Inventors: Leena Peltonen, Nabil Enattah, Irma Järvelä, Timo Sahi, Erkki Savilahti, Joseph Terwilliger
  • Identification of a DNA variant associated with adult type hypolactasia
    Patent number: 8252537
    Abstract: The present invention relates to a nucleic acid molecule comprising a 5? portion of an intestinal lactase-phlorizine hydrolase (LPH) gene contributing to or indicative of the adult-type hypolactasia. The present invention further relates to methods for testing for the presence of or predisposition to adult-type hypolactasia that are based on the analysis of an SNP contained in the above recited nucleic acid molecule. Additionally, the present invention relates to diagnostic composition and kit useful in the detection of the presence of or predisposition to adult-type hypolactasia.
    Type: Grant
    Filed: February 9, 2004
    Date of Patent: August 28, 2012
    Assignee: National Public Health Institute
    Inventors: Leena Peltonen, Nabil Enattah, Irma Jarvela, Timo Sahi, Erkki Savilahti, Joseph Terwilliger
  • Identification of a DNA variant associated with adult type hypolactasia
    Publication number: 20040265856
    Abstract: The present invention relates to a nucleic acid molecule comprising a 5′ portion of an intestinal lactase-phlorizine hydrolase (LPH) gene contributing to or indicative of the adult-type hypolactasia wherein said nucleic acid molecule is selected from the group consisting of (a) a nucleic acid molecule having or comprising the nucleic acid sequence of SEQ ID NO: 1, the sequence of SEQ ID NO:1 is also depicted in FIG. 4 and comprised in the sequence as depicted in FIG. 8; (b) a nucleic acid molecule having or comprising the nucleic acid sequence of SEQ ID NO: 2, the sequence of SEQ ID NO:2 is also depicted in FIG. 5 and comprised in the sequence as depicted in FIG.
    Type: Application
    Filed: February 9, 2004
    Publication date: December 30, 2004
    Applicant: National Public Health Institute
    Inventors: Leena Peltonen, Nabil Enattah, Irma Jarvela, Timo Sahi, Erkki Savilahti, Joseph Terwilliger